Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2014, Vol. 8 Issue (3) : 321-327    https://doi.org/10.1007/s11684-014-0370-y
RESEARCH ARTICLE
Clinical research of traditional Chinese medicine in big data era
Junhua Zhang1, Boli Zhang1,2()
1. Tianjin University of Traditional Chinese Medicine, Tianjin 210029, China
2. China Academy of Chinese Medical Sciences, Beijing 100700, China
 Download: PDF(106 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

With the advent of big data era, our thinking, technology and methodology are being transformed. Data-intensive scientific discovery based on big data, named “The Fourth Paradigm,” has become a new paradigm of scientific research. Along with the development and application of the Internet information technology in the field of healthcare, individual health records, clinical data of diagnosis and treatment, and genomic data have been accumulated dramatically, which generates big data in medical field for clinical research and assessment. With the support of big data, the defects and weakness may be overcome in the methodology of the conventional clinical evaluation based on sampling. Our research target shifts from the “causality inference” to “correlativity analysis.” This not only facilitates the evaluation of individualized treatment, disease prediction, prevention and prognosis, but also is suitable for the practice of preventive healthcare and symptom pattern differentiation for treatment in terms of traditional Chinese medicine (TCM), and for the post-marketing evaluation of Chinese patent medicines. To conduct clinical studies involved in big data in TCM domain, top level design is needed and should be performed orderly. The fundamental construction and innovation studies should be strengthened in the sections of data platform creation, data analysis technology and big-data professionals fostering and training.

Keywords big data      traditional Chinese medicine      clinical evaluation      evidence based medicine     
Corresponding Author(s): Boli Zhang   
Online First Date: 16 September 2014    Issue Date: 09 October 2014
 Cite this article:   
Junhua Zhang,Boli Zhang. Clinical research of traditional Chinese medicine in big data era[J]. Front. Med., 2014, 8(3): 321-327.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-014-0370-y
https://academic.hep.com.cn/fmd/EN/Y2014/V8/I3/321
1 WHO. Life in the 21st Century: a vision for all. World Health Rep 2008
2 AD Weston, L Hood. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res 2004; 3(2): 179–196
https://doi.org/10.1021/pr0499693 pmid: 15113093
3 P Craig, P Dieppe, S Macintyre, S Michie, I Nazareth, M Petticrew. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008; 337: a1655
4 LL Craven. Prevention of coronary thrombosis and acetylsalicylic acid. Miss Valley Med J 1956; 78: 213–215
pmid: 13358612
5 Editorial. Aspirin after myocardial infarction. Lancet 1980; 315(8179): 1172–1173
pmid: 6103990
6 ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 332(8607): 349–360
pmid: 2899772
7 S Yusuf, R Collins, R Peto. Why do we need some large, simple randomized trials? Stat Med 1984; 3(4): 409–422
https://doi.org/10.1002/sim.4780030421 pmid: 6528136
8 J Worrall. Do We Need Some Large, Simple Randomized Trials in Medicine? EPSA Philosophical Issues in the Sciences. London, UK: Springer, 2010
9 Nature. Big Data[EB/OL]. 2012.
10 Office of Science and Technology Policy. Big Data across the Federal Government. 2012-March- 29
11 ZH Li, GR Wang, AY Zhou. Research progress and trends of big data from a database perspective. Comput Eng Sci(Ji Suan Ji Ke Xue Yu Ji Shu) 2013; 35(10): 1–11 (in Chinese)
12 T Hey, S Tansley, K Tolle. The Fourth Paradigm: data-intensive scientific discovery. Microsoft, 2009-October- 16
13 China Hospital Information Management Association. Chinese Hospital Informationization Development Research Report (white paper). 2008 (in Chinese)
14 GH Zhou, Y Xin, YJ Zhang, T Hu, YF Li. Study on big data’s applications in medical and health field. Chin J Health Inf Manag (Zhongguo Wei Sheng Xin Xi Guan Li Za Zhi) 2013; 110(4): 296–300, 304 (in Chinese)
15
16 amazon.com website
17 DQ Xu, HQ Yang. The application of big data on healthcare personalized service. Chin J Health Inf Manag (Zhongguo Wei Sheng Xin Xi Guan Li Za Zhi) 2013; 110(4): 301–304 (in Chinese)
18 J Cohen, B Dolan, M Dunlap, JM Hellerstein, C Welton. MAD skills: new analysis practices for big data. PVLDB 2009; 2(2): 1481–1492
19 Y Song, DY Wang. Challenges and opportunities of clinical research in the big data era. J Med Postgra (Yi Xue Yan Jiu Sheng Xue Bao) 2014; 27(4): 337–339 (in Chinese)
20 H Shang, J Zhang, C Yao, B Liu, X Gao, M Ren, H Cao, G Dai, W Weng, S Zhu, H Wang, H Xu, B Zhang. Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. Evid Based Complement Alternat Med 2013; 2013: 738391
https://doi.org/10.1155/2013/738391 pmid: 23935677
21 consort-statement.org website
22 P Li. Three transitions of hospital informatization in the era of cloud computing and big data. Chin Hosp Manag (Zhongguo Yi Yuan Guan Li) 2013; 33(12): 80–81 (in Chinese)
23 BY Liu. Clinical research paradigm of traditional Chinese medicine in the real world. J Tradit Chin Med (Zhong Yi Za Zhi) 2013; 54(6): 451–455 (in Chinese)
24 XF Meng, X Ci. Big data management: concepts, techniques and challenges. J Comput Res Dev (Ji Suan Ji Yan Jiu Yu Fa Zhan) 2013; 50(1): 146–169 (in Chinese)
25 Data, data everywhere. The Economist Feb 25th 2010.
[1] Qiaoli Shi, Fei Xia, Qixin Wang, Fulong Liao, Qiuyan Guo, Chengchao Xu, Jigang Wang. Discovery and repurposing of artemisinin[J]. Front. Med., 2022, 16(1): 1-9.
[2] Ling Dai, Xiang Gao, Zhihua Ye, Hanmin Li, Xin Yao, Dingbo Lu, Na Wu. The “Traditional Chinese medicine regulating liver regeneration” treatment plan for reducing mortality of patients with hepatitis B-related liver failure based on real-world clinical data[J]. Front. Med., 2021, 15(3): 495-505.
[3] Mengxue Huang, Jingjing Wang, Runshun Zhang, Zhuying Ni, Xiaoying Liu, Wenwen Liu, Weilian Kong, Yao Chen, Tiantian Huang, Guihua Li, Dan Wei, Jianzhong Liu, Xuezhong Zhou. Symptom network topological features predict the effectiveness of herbal treatment for pediatric cough[J]. Front. Med., 2020, 14(3): 357-367.
[4] Qiqi Zhao, Xin Gao, Guangli Yan, Aihua Zhang, Hui Sun, Ying Han, Wenxiu Li, Liang Liu, Xijun Wang. Chinmedomics facilitated quality-marker discovery of Sijunzi decoction to treat spleen qi deficiency syndrome[J]. Front. Med., 2020, 14(3): 335-356.
[5] Yuan Gao, Zhilei Wang, Jinfa Tang, Xiaoyi Liu, Wei Shi, Nan Qin, Xiaoyan Wang, Yu Pang, Ruisheng Li, Yaming Zhang, Jiabo Wang, Ming Niu, Zhaofang Bai, Xiaohe Xiao. New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus induces idiosyncratic hepatotoxicity under immunological stress conditions[J]. Front. Med., 2020, 14(1): 68-80.
[6] Hudan Pan, Yanfang Zheng, Zhongqiu Liu, Zhongwen Yuan, Rutong Ren, Hua Zhou, Ying Xie, Liang Liu. Deciphering the pharmacological mechanism of Guan-Jie-Kang in treating rat adjuvant-induced arthritis using omics analysis[J]. Front. Med., 2019, 13(5): 564-574.
[7] Li Ma, Bin Wang, Yuanxiong Long, Hanmin Li. Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis[J]. Front. Med., 2017, 11(2): 191-202.
[8] Yunfang Liu,Zhiping Yang,Jing Cheng,Daiming Fan. Barriers and countermeasures in developing traditional Chinese medicine in Europe[J]. Front. Med., 2016, 10(3): 360-376.
[9] Yan Ma,Kehua Zhou,Jing Fan,Shuchen Sun. Traditional Chinese medicine: potential approaches from modern dynamical complexity theories[J]. Front. Med., 2016, 10(1): 28-32.
[10] Zhuyuan Fang, Xiaowei Fan, Gong Chen. A study on specialist or special disease clinics based on big data[J]. Front. Med., 2014, 8(3): 376-381.
[11] Jian Wang, Biyan Liang, Xiaoping Zhang, Liran Xu, Xin Deng, Xiuhui Li, Lu Fang, Xinghua Tan, Yuxiang Mao, Guoliang Zhang, Yuguang Wang. An 84-month observational study of the changes in CD4 T-lymphocyte cell count of 110 HIV/AIDS patients treated with traditional Chinese medicine[J]. Front. Med., 2014, 8(3): 362-367.
[12] Guozheng Li, Xuewen Zuo, Baoyan Liu. Scientific computation of big data in real-world clinical research[J]. Front. Med., 2014, 8(3): 310-315.
[13] Yan Ma, Shuchen Sun, Chung-Kang Peng. Applications of dynamical complexity theory in traditional Chinese medicine[J]. Front. Med., 2014, 8(3): 279-284.
[14] Xuezhong Zhou,Yubing Li,Yonghong Peng,Jingqing Hu,Runshun Zhang,Liyun He,Yinghui Wang,Lijie Jiang,Shiyan Yan,Peng Li,Qi Xie,Baoyan Liu. Clinical phenotype network: the underlying mechanism for personalized diagnosis and treatment of traditional Chinese medicine[J]. Front. Med., 2014, 8(3): 337-346.
[15] Runshun Zhang,Yinghui Wang,Baoyan Liu,Guangli Song,Xuezhong Zhou,Shizhen Fan,Xishui Pan. Clinical data quality problems and countermeasure for real world study[J]. Front. Med., 2014, 8(3): 352-357.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed